ReviewThe Journal of international medical research2019

Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.